Tradestie Institutional Equity Comparison Engine

BUDA vs EXOZ โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

BUDA Overall Edge

BUDA Captures Institutional Edge (2โ€“1 Pillars ยท 1โ€“6 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to BUDA (BUDA) driven by superior Momentum & Technical, Options & Structure while EXOZ counters with relative strength in Growth & Margin. Fundamentally, BUDA trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus EXOZ at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, BUDA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against EXOZ sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
BUDA N/M vs EXOZ N/M Fwd P/E
Growth & Margin Winner EXOZ
Op Margin N/A vs 0.0% ยท YoY N/A vs +0.0%
Momentum & Technical Winner BUDA
1Y -34.6% vs -81.0% ยท 52W Pos 1% vs 1%
Options & Structure Winner BUDA
UNCLASSIFIED (N/A IV) vs BREAKDOWN (N/A IV)
BUDA US Equity
BUDA
Institutional Equity
$5.30
-0.19% 1D
Market Cap N/A
1M Return -20.9%
1Y Return -34.65%
Forward P/E N/M
Unified AI Score
34.2 / 100 SELL
Tech 35.0 Fund 42.0 Flow 50.0 Mom 55.0
EXOZ NASDAQ
eXoZymes Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$2.90
-14.05% 1D
Market Cap $31.9M
1M Return -25.51%
1Y Return -80.96%
Forward P/E N/M
Unified AI Score
42.3 / 100 HOLD
Tech 25.0 Fund 51.0 Flow 50.0 Mom 59.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: BUDA -34.65% EXOZ -80.96% Spread: +35.34 pp (BUDA Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
BUDA TTM Op. Margin: N/A EXOZ TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BUDA vs EXOZ. Trailing 12-month operating profitability (BUDA N/A vs EXOZ 0.0%) and valuation multiples (BUDA N/M vs EXOZ N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: BUDA (1) vs EXOZ (6)
Institutional Metric BUDA EXOZ Criterion Row Winner
Market Capitalization Scale N/A $31.9M Larger Scale EXOZ
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth N/A +0.0% Higher Growth EXOZ
Operating Margin (TTM) Profitability N/A 0.0% Higher Margin EXOZ
Net Profit Margin Profitability N/A 0.0% Higher Margin EXOZ
Return on Equity (ROE) Capital Efficiency N/A -187.2% Higher ROE EXOZ
52-Week Range Position Momentum 1% ($5โ€“$12) 1% ($3โ€“$17) Stronger Trend Tie
Beta / 30D Volatility Risk Regime -0.03ฮฒ ยท 71% Vol 1.00ฮฒ ยท 109% Vol Lower Realized Risk BUDA
Unified Institutional Score Composite Signal 34.2 / 100 (SELL) 42.3 / 100 (HOLD) Higher Composite EXOZ

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full BUDA vs EXOZ Buy Guide
BUDA UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live BUDA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
EXOZ BREAKDOWN
57d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live EXOZ Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither BUDA nor EXOZ registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.